[go: up one dir, main page]

WO2004027018A3 - Dosage de cellule kinase a adhesion focale inductible - Google Patents

Dosage de cellule kinase a adhesion focale inductible Download PDF

Info

Publication number
WO2004027018A3
WO2004027018A3 PCT/IB2003/003968 IB0303968W WO2004027018A3 WO 2004027018 A3 WO2004027018 A3 WO 2004027018A3 IB 0303968 W IB0303968 W IB 0303968W WO 2004027018 A3 WO2004027018 A3 WO 2004027018A3
Authority
WO
WIPO (PCT)
Prior art keywords
fak
cell assay
focal adhesion
adhesion kinase
kinase cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IB2003/003968
Other languages
English (en)
Other versions
WO2004027018A2 (fr
Inventor
Walter Gregory Roberts
Pamela Matthews Whalen
Ethan James Tekly Ung
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Products Inc
Original Assignee
Pfizer Products Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc filed Critical Pfizer Products Inc
Priority to JP2004537413A priority Critical patent/JP2006500022A/ja
Priority to EP03797456A priority patent/EP1546372A4/fr
Priority to AU2003259498A priority patent/AU2003259498A1/en
Priority to CA002497434A priority patent/CA2497434A1/fr
Publication of WO2004027018A2 publication Critical patent/WO2004027018A2/fr
Publication of WO2004027018A3 publication Critical patent/WO2004027018A3/fr
Anticipated expiration legal-status Critical
Priority to NO20051869A priority patent/NO20051869L/no
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/91—Transferases (2.)
    • G01N2333/912—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • G01N2333/91205—Phosphotransferases in general

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

L'invention concerne un dosage cellulaire qui exploite le biologie de FAK conjointement avec un système d'expression génique inductible afin de contrôler depuis l'extérieur l'expression de FAK et la phosphorylation de FAK du résidu de tyrosine au niveau de la position 397 (Y397). Ce dosage de cellule kinase de l'invention est flexible et peut mesurer le phosphorylation de FAK au niveau de Y397, la phosphorylation de FAK totale, identifier les protéines de FAK mutantes et mesurer une combinaison de protéine et de phosphotyrosine.
PCT/IB2003/003968 2002-09-19 2003-09-08 Dosage de cellule kinase a adhesion focale inductible Ceased WO2004027018A2 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
JP2004537413A JP2006500022A (ja) 2002-09-19 2003-09-08 誘導可能な局所接着キナーゼ細胞アッセイ
EP03797456A EP1546372A4 (fr) 2002-09-19 2003-09-08 Dosage de cellule kinase a adhesion focale inductible
AU2003259498A AU2003259498A1 (en) 2002-09-19 2003-09-08 Inducible focal adhesion kinase cell assay
CA002497434A CA2497434A1 (fr) 2002-09-19 2003-09-08 Dosage de cellule kinase a adhesion focale inductible
NO20051869A NO20051869L (no) 2002-09-19 2005-04-18 Celleanalyse av induserbare focal adhesjonskinase

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41207802P 2002-09-19 2002-09-19
US60/412,078 2002-09-19

Publications (2)

Publication Number Publication Date
WO2004027018A2 WO2004027018A2 (fr) 2004-04-01
WO2004027018A3 true WO2004027018A3 (fr) 2004-09-16

Family

ID=32030798

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2003/003968 Ceased WO2004027018A2 (fr) 2002-09-19 2003-09-08 Dosage de cellule kinase a adhesion focale inductible

Country Status (9)

Country Link
EP (1) EP1546372A4 (fr)
JP (1) JP2006500022A (fr)
KR (1) KR20050052663A (fr)
CN (1) CN1681939A (fr)
AU (1) AU2003259498A1 (fr)
CA (1) CA2497434A1 (fr)
NO (1) NO20051869L (fr)
RU (1) RU2005107701A (fr)
WO (1) WO2004027018A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100934706B1 (ko) * 2006-12-07 2009-12-31 재단법인서울대학교산학협력재단 Ｔｍ４ｓｆ５의 기능을 저해하는 항암물질의 스크리닝 방법및 칼콘계 화합물을 함유하는 항암조성물
WO2009046129A2 (fr) * 2007-10-01 2009-04-09 Columbia University Procédés de traitement du syndrome de détresse respiratoire de l'adulte
CN109112213B (zh) * 2017-06-22 2021-01-12 中国科学院动物研究所 检测黏着斑激酶结构变异体的pcr引物及其检测方法与应用
KR102007450B1 (ko) 2018-05-31 2019-08-05 한국과학기술연구원 대장암 치료제 발굴을 위한 신규 표적 치료 작용점의 스크리닝 방법 및 이를 이용하여 선별한 대장암 치료 예후 바이오마커
KR102408538B1 (ko) * 2020-10-29 2022-06-15 한국과학기술연구원 Fak 활성 억제제를 스크리닝하기 위한 조성물, 키트 및 방법

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6133031A (en) * 1999-08-19 2000-10-17 Isis Pharmaceuticals Inc. Antisense inhibition of focal adhesion kinase expression

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6395506B1 (en) * 1991-04-18 2002-05-28 Becton, Dickinson And Company Device for monitoring cells
DK0948604T3 (da) * 1996-12-11 2004-11-22 Sugen Inc Screeningsmetoder for forbindelser som binder til PYK2-polypeptidet
WO1999028750A1 (fr) * 1997-12-03 1999-06-10 The University Of North Carolina At Chapel Hill Proteines frnk pour le traitement de cellules cancereuses

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6133031A (en) * 1999-08-19 2000-10-17 Isis Pharmaceuticals Inc. Antisense inhibition of focal adhesion kinase expression

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
HEIDKAMP M.C.: "Activation of focal adhesion kinase by protein kinase C.epsilon. in neonatal rat ventricular myocytes", AM. J. PHYSIOL. HEART CIRC. PHYSIOL., vol. 285, 26 June 2003 (2003-06-26), pages H1684 - H1696, XP002979010 *
RODRIGUEZ-FERNANDEZ J.L.: "Bombesin, Vasopressin, Lysophosphatidic Acid, and Sphingosylphosphorylcholine Induce Focal Adhesion Kinase Activation in Intact Swiss 3T3 Cells", J. BIOL. CHEM., vol. 273, no. 30, 24 July 1998 (1998-07-24), pages 19321 - 19328, XP002978736 *
See also references of EP1546372A4 *

Also Published As

Publication number Publication date
EP1546372A2 (fr) 2005-06-29
KR20050052663A (ko) 2005-06-03
RU2005107701A (ru) 2005-08-27
NO20051869L (no) 2005-06-16
WO2004027018A2 (fr) 2004-04-01
JP2006500022A (ja) 2006-01-05
CA2497434A1 (fr) 2004-04-01
EP1546372A4 (fr) 2006-08-23
AU2003259498A1 (en) 2004-04-08
CN1681939A (zh) 2005-10-12
NO20051869D0 (no) 2005-04-18

Similar Documents

Publication Publication Date Title
WO2005100602A3 (fr) Biocapteurs bases sur un assemblage dirige de particules
EP1757689A3 (fr) Famille de gènes mammaliens de protéines inhibant l'apoptose (iap), amorces, sondes et procédés de détection
CA2448703A1 (fr) Matrice enzymatique reticulee et utilisations associees
WO2002090923A3 (fr) Procede d'assemblage de microreseaux de proteines
WO2002018639A3 (fr) Detection de polymorphismes cyp2c19
WO2004052046A3 (fr) Transducteur a membrane mince
ES2178715T3 (es) Sensor electroquimico de peroxidasa de soja.
WO2002088346A3 (fr) Systeme destine a l'expression inductible dans des cellules eucariotes
WO2004046690A3 (fr) Membrane de capteur composite
ZA200307442B (en) Methods using O6-alkylguanine-DNA alkyl transferases.
CA2294516A1 (fr) Proteines ikk-.beta., acides nucleiques et procedes
AU2003253784A1 (en) Peptides from the e2, e6 and e7 proteins of human papillomaviruses 16 and 18 for detecting and/or diagnosing cervical and other cancers
AU2001269709A1 (en) Nucleic acids, vectors, host cells, polypeptides, and uses thereof
EP0871029A3 (fr) Capteur d'hydrogène en film mince
EP1005539A4 (fr) PROTEINES IKK-$g(a), ACIDES NUCLEIQUES ET PROCEDES
WO2004027018A3 (fr) Dosage de cellule kinase a adhesion focale inductible
WO2003066828A3 (fr) Bibliotheques en doigt de gant
WO2003034025A3 (fr) Procedes et reactifs permettant des dosages cellulaires ameliores
WO1997042343A3 (fr) Enzymes d'acide teichoïque et dosages
WO2002024941A3 (fr) Regulation de proteine kinase
AU3063699A (en) Isolated mammalian membrane protein genes and related reagents
AU1183200A (en) Novel gene encoding brain-specific membrane protein
WO2003010335A3 (fr) Variation de la sequence du recepteur de l'il-4 associee aux diabetes de type 1
EP1177213A4 (fr) Gene derive de lawsonia, polypeptides, peptides et proteines d'hemolysine et leurs utilisations
WO2003091447A3 (fr) Acides nucleiques d1-1, polypeptides et methodes associees

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 512/DELNP/2005

Country of ref document: IN

WWE Wipo information: entry into national phase

Ref document number: 166872

Country of ref document: IL

WWE Wipo information: entry into national phase

Ref document number: 2003259498

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2497434

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2003797456

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2005107701

Country of ref document: RU

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 1020057004717

Country of ref document: KR

Ref document number: 2004537413

Country of ref document: JP

Ref document number: 20038221519

Country of ref document: CN

WWP Wipo information: published in national office

Ref document number: 1020057004717

Country of ref document: KR

WWP Wipo information: published in national office

Ref document number: 2003797456

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2003797456

Country of ref document: EP